Investment Analysts' Recent Ratings Changes for Regeneron Pharmaceuticals

Home › Investment Analysts' Recent Ratings Changes for Regeneron Pharmaceuticals

They now have a "buy" rating on the stock. 5/15/2015 - Regeneron Pharmaceuticals had its price target raised by analysts at JPMorgan Chase & Co.

29.09	When to recline and how to share armrests: Rules for avoiding a mid-flight row
29.09	Atlantic Tropical Weather Outlook
29.09	Eastern North Pacific Tropical Weather Outlook
28.09	Hurricane Isaac Graphics
28.09	Hurricane Isaac Forecast Discussion Number 12
28.09	Tropical Storm Joyce Graphics
28.09	Hurricane Isaac Wind Speed Probabilities Number 12
28.09	Hurricane Isaac Forecast Advisory Number 12
More »

je.st